Sandra A. Gardiner - 17 Apr 2023 Form 3 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role: Chief Financial Officer
Signature: Mark A. Wilson, Attorney-in-Fact
Issuer symbol: NKTR
Transactions as of: 17 Apr 2023
Transactions value $: $0
Form type: 3
Filing time: 25 Apr 2023, 21:03:08
Previous filing: 04 Apr 2023
Next filing: 18 Sep 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Ex-24 Power of Attorney